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A B S T R A C T
The one-pot, simple and efﬁcient three-component condensation protocol for the preparation of a series
of twenty-ﬁve new 3-acyl-4-aryl-2-(triﬂuoromethyl)-2-hydroxy-3,4,7,8-tetrahydro-2H-chromen-
5(6H)-ones, where aryl = Ph, 4-tolyl, 4-ClPh, 4-NO2Ph and 4-CHOPh, and acyl = Ac, Bz, 4-FBz, furan-
2-oyl, thien-2-oyl and naphth-1-oyl, employing 1,3-cyclohexanedione, ﬁve aryl aldehydes and for the
ﬁrst time, six 4-alkyl(aryl/heteroaryl)-4-methoxy-1,1,1-triﬂuoroalk-3-en-2-ones, is described. Yields in
15–75% were obtained when the MCRs were performed in the presence of a catalytic amount of
triethylamine (25 mol%) and in ethanol as solvent under reﬂux for 16 h. A representative X-ray
diffraction data for 3-acetyl-4-phenyl-2-(triﬂuoromethyl)-2-hydroxy-3,4,7,8-tetrahydro-2H-chromen-
5(6H)-one is also showed.
 2010 Elsevier B.V.
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The development of multicomponent reactions (MCRs) is
nowadays of great importance in synthetic organic chemistry,
since they offer one-pot combinations of two or more components
in one step, allowing the formation of molecules with more
complex structures [1]. In addition, the design of MCRs to produce
elaborate active compounds has become an important area of
research in combinatorial and medicinal chemistry [2]. This
approach holds a number of advantages over conventional
methodologies, such as ﬂexibility, convergence, simple starting
materials and products in high yield [3].
On another vein, due to their unique physical, chemical, and
biological properties, ﬂuorine-containing compounds have
attracted much attention in the ﬁeld of biological and material
science. Speciﬁcally, triﬂuoromethyl substituted heterocyles are
becoming increasingly important for the development of new
agrochemicals and medications [4–6]. Among many useful
reactions, the introduction of a triﬂuoromethyl group has received* Corresponding author. Fax: +55 55 3220 8031.
E-mail address: heliogb@base.ufsm.br (H.G. Bonacorso).
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Open access under the Elsevier OA license.great attention in the literature [7], where methyl ﬂuorosulfo-
nyldiﬂuoroacetate (MFSDA), as a convenient-to-handle liquid
reagent, has allowed the synthesis of a variety of CF3-containing
compounds including aryl, heteroaryl, vinyl, benzyl and allyl
halides in good yields and under mild conditions.
However, one of the best methods to introduce a triﬂuor-
omethyl group into heterocycles is based on the triﬂuoromethy-
lated building block approach. This approach relies on the
triﬂuoroacetylation of enolethers or acetals to give, in one-step
and good yields, 4-alkoxy-4-alkyl(aryl/heteroaryl)-1,1,1-triﬂuor-
oalk-3-en-2-ones which have proven to be useful building blocks
for the regioselective synthesis of numerous triﬂuoromethyl
substituted heterocycles [8].
Funcionalized chromenes and benzopyrans are an important
class of compounds which have received considerable attention
due to their wide range biological and pharmacological activities
such as spasmolytic, diuretic, anti-coagulant, anti-cancer, and anti-
anaphylactic [9]. Furthermore, they can be employed as pigments,
photoactive materials and utilized as biodegradable agrochem-
icals, as well as, constituent of the structural unit of a series of
natural products [10,11]. Many methods have been introduced for
the synthesis of these compounds, such as, from aromatic
aldehydes and cyclohexane-1,3-diones [11], a,b-unsaturated
Scheme 1. Reaction conditions: (i) ethanol, Et3N (25 mol%), reﬂux,16 h.
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catalytic amount of diarylprolinol silyl ether [12], organocatalytic
enantioselective addition of ﬁve-, six- and seven-membered 1,3-
cycloalkanediones to a,b-unsatured aldehydes [13], Michael
reaction of b,g-unsatured a-ketoesteres with cyclic 1,3-diketones
[14] and from a one-pot three-component reaction of 1,3-
cyclohexanedione with aryl aldehydes and 4,4,4-triﬂuoro-1-
(thien-2-yl)butane-1,3-dione in the presence of a catalytic amount
of triethylamine [3].
Although some similar compounds already have been de-
scribed, so far, the employment of 4-methoxy-1,1,1-triﬂuoro-3-
alken-2-ones by a three-component condensation reaction to
obtain triﬂuoromethyl substituted 2-hydroxy-2H-chromenones
was not yet reported.
Thus, the aim of this work is to report a facile and efﬁcient
synthesis of 2-triﬂuoromethyl-2H-chromenones using MCR meth-
odology, which employs as starting materials 1,3-cyclohexane-
dione, aryl aldehydes (ﬁve examples) and 4-methoxy-1,1,1-
triﬂuoroalk-3-en-2-ones (six examples) to show a new chemical
behavior of this triﬂuoromethylated building block, in a [4+2]
cyclocondensation reaction, and a new method to introduce the
triﬂuoromethyl group into molecules that are of great interest to
organic and medicinal chemists.Scheme 2. A plausible mechanism fo2. Results and discussion
4-Methoxy-4-alkyl(aryl/heteroaryl)-1,1,1-triﬂuoroalk-3-en-2-
ones (3a–f) are readily available CCC synthetic blocks and were
prepared from triﬂuoroacetylation reactions of commercially
available iso-propenyl methyl ether (for 3a) or generated in situ
of the respective aryl- (for 3b–c, 3f) or heteroaryl (for 3d–e)methyl
ketone acetals with triﬂuoroacetic anhydride, respectively, in the
presence of pyridine, as described in the literature [15].
We initially examined the MCR involving 4-methoxy-1,1,1-
triﬂuoropent-3-en-2-one (3a), benzaldehyde (2a) and 1,3-cyclo-
hexanedione in ethanol as solvent in the absence of a base
employing stirring from 2 to 24 h at room temperature under
reﬂux. Under this reaction condition, no precipitation products
were observed in the course of the reaction, nor were any products
identiﬁed by 1H NMR experiments. Although some organic bases
and polar protic or aprotic solventswere tested, the best conditions
for the consumption of the starting materials to form 4aa were
only when the reactions were carried out in the presence of a
catalytic amount of triethylamine or pyridine under reﬂuxing
ethanol. The experiments also showed that 25–30 mol% of catalyst
was necessary to complete the reaction after 16 h under reﬂux and
higher amounts of catalyst (up to 60 mol% of triethylamine orr formation of chromenones 4.
Table 1
Regioselective multicomponent reaction for the synthesis of 3,4,7,8-tetrahydro-2H-chromen-5(6H)-ones.
Entry Ar R Product Mp (8C) Yield (%)b
1 C6H5 (2a) CH3 (3a) 4aa 175–176 (203–204)
c 45 (53)c
2 C6H5 (2a) C6H5 (3b) 4ab 187–189 54
3 C6H5 (2a) 4-FC6H4 (3c) 4ac 173–175 60
4 C6H5 (2a) 2-Furyl (3d) 4ad 190–191 47
5 C6H5 (2a) 2-Thienyl (3e) 4ae 187–189 (222–223)
c 50 (68)c
6 C6H5 (2a) 1-Naphthyl (3f) 4af 199–200 12
7 4-CH3C6H4 (2b) CH3 (3a) 4ba 172–174 60
8 4-CH3C6H4 (2b) C6H5 (3b) 4bb 176–178 64
9 4-CH3C6H4 (2b) 4-FC6H4 (3c) 4bc 202–203 58
10 4-CH3C6H4 (2b) 2-Furyl (3d) 4bd 194–196 65
11 4-CH3C6H4 (2b) 2-Thienyl (3e) 4be 187–189 (216–218)
c 63 (88)c
12 4-CH3C6H4 (2b) 1-Naphthyl (3f) 4bf 198–200 18
13 4-ClC6H4 (2c) CH3 (3a) 4ca 184–186 66
14 4-ClC6H4 (2c) C6H5 (3b) 4cb 189–191 75
15 4-ClC6H4 (2c) 4-FC6H4 (3c) 4cc 187–189 68
16 4-ClC6H4 (2c) 2-Furyl (3d) 4cd 189–191 64
17 4-ClC6H4 (2c) 2-Thienyl (3e) 4ce 181–183 (224–225)
c 71 (60)c
18 4-ClC6H4 (2c) 1-Naphthyl (3f) 4cf 199–201 22
19 4-NO2C6H4 (2d) CH3 (3a) 4da 194–196 53
20 4-NO2C6H4 (2d) C6H5 (3b) 4db 182–184 65
21 4-NO2C6H4 (2d) 4-FC6H4 (3c) 4dc 177–179 51
22 4-NO2C6H4 (2d) 2-Furyl (3d) 4dd 209–211 49
23 4-NO2C6H4 (2d) 2-Thienyl (3e) 4de 205–207 (230–231)
c 57 (66)c
24 4-NO2C6H4 (2d) 1-Naphthyl (3f) 4df 206–208 16
25 4-CHOC6H4 (2e) CH3 (3a) 4ea 194–196 41
26 4-CHOC6H4 (2e) C6H5 (3b) 4eb 182–184 43
27 4-CHOC6H4 (2e) 4-FC6H4 (3c) 4ec 182–184 45
28 4-CHOC6H4 (2e) 2-Furyl (3d) 4ed 202–204 60
29 4-CHOC6H4 (2e) 2-Thienyl (3e) 4ee 198–200 52
30 4-CHOC6H4 (2e) 1-Naphthyl (3f) 4ef 189–191 15
a Molar ratio 1:2a–e:3a–f=1:1:1.
b Yield of isolated.
c Yields and melting points from Ref. [3].
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this result, we then employed this reaction as a template to
optimize the reaction conditions. According to Song et al. [3], when
the reaction started from 4,4,4-triﬂuoro-1-(thien-2-yl)butane-1,3-
dione, as the 1,3-dicarbonyl acyclic precursor, 2–24 h were
necessary to ﬁnish the reaction resulting in 36–88% yield and
depending on the aryl aldehyde substituent. In the present study,
16 hwere determined as the optimal reaction time for all ketones 3
and aldehydes 2 precursors (Scheme 1).
Subsequently, we synthesized a series of thirty triﬂuoromethyl
substituted 3,4,7,8-tetrahydro-2H-chromen-5(6H)-one deriva-
tives (4aa–ef), where ﬁve chromenones are known-compounds
[3], named 4aa, 4ae, 4be, 4ce and 4de, by a three-component
protocol employing a 1,3-dicarbonyl cyclic compound (1,3-
cyclohexanedione), ﬁve aryl aldehydes (2a–e) containing elec-
tron-withdrawing and electron-donating groups and six 4-alkyl-,
4-aryl- and 4-heteroaryl-substituted 4-methoxy-1,1,1-triﬂuor-
oalk-3-en-2-ones (3a–f).
A plausible and simpliﬁed mechanism for the multicomponent
synthesis of chromenones 4 using triethylamine in ethanol at
reﬂux is proposed in Scheme 2. One of the most general mixedaldol condensation reactions involves the use of aromatic
aldehydes with 1,3-diketones. Aromatic aldehydes are incapable
of enolization and cannot function as the nucleophilic component.
Dehydration is especially favorable because the resulting enone is
conjugated with the aromatic ring. Moreover, there are numerous
examples of both acid- and base-catalyzed mixed aldol condensa-
tions involving aromatic aldehydes. On the other hand, the
nucleophilic proprieties of 4-ethoxy-1,1,1-triﬂuorobut-3-en-2-
one were studied in much more detail in the diacylation reactions
of alkyl vinyl ethers [23a], [2+3] dipolar cycloaddition involving
nitrones [23b] and a-halogenation [23c], but the reactions of
ﬂuorinated enones 3 with electrophiles, as demonstrated in the
present work, have not been yet reported. Thus, in our case, we
think that triethylamine is sufﬁciently basic to promote a
Knoevenagel condensation of the aromatic aldehyde (2) with
one molecule of 1,3-hexanedione to give the dehydrated Knoe-
venagel product. The subsequent Michael addition of the 4-
methoxy-1,1,1-triﬂuoroalk-3-en-2-one (3) to the Knoevenagel
product, in a [4+2] cyclocondensation reaction type, with
subsequent water addition to the exocyclic oxymethylated carbon
and followed by the hydrolysis of the hemiacetal function, allowed
Fig. 1. A perspective view of 3-acetil-4-phenyl-2-(triﬂuoromethyl)-2-hydroxy-
3,4,7,8-tetrahydro-2H-chromen-5(6H)-one (4aa) with atoms labeled (CCDC
774510) [16]. Displacement ellipsoids are drawn at the 50% probability level.
H.G. Bonacorso et al. / Journal of Fluorine Chemistry 132 (2011) 160–165 163the isolation of the chromenones 4. However, the exact sequence of
intermediates is difﬁcult to determine since many of the steps are,
expected, in equilibrium.
As a result, twenty-ﬁve chromen-5(6H)-ones 4were obtained in
satisfactory to good yields (41–75%), but poor yields (15–22%)
were veriﬁed for the synthesis of ﬁve 3-(naphth-1-oyl) derivatives
(4af–ef), although the reaction time was prolonged up to 48 h
under reﬂux. Even so, many times no precipitated products were
observed in the reaction mixture and a more laborious reaction
work-up was necessary after the end of the reaction. For all other
compounds, the products precipitated in the course of the reaction
and after the reaction time, the desired compounds were ﬁltered,
washed with cold ethanol and air-dried. Subsequently, a recrys-
tallization from ethanol/ethylacetate (2:1) and drying in a
desiccator under reduced pressure over P2O5, furnished 4 in high
purity (elemental analysis). The summary of the results of all
reactions and the melting point with the literature data for known
compounds are shown in Table 1.
With the exception of 3-(naphth-1-oyl) derivatives (4af–ef), it
was also observed that the reaction yieldswere not very sensitive to
the presence, or lack, of a Y-substituent at the para-position of the
aryl aldehydes, nor to the R-substituent effect of the vinyl ketones 3.
The electronic and steric effects of the aryl substituents from the
aldehydes 2 and the naphthyl group of the triﬂuoromethylated
enone 3 in the cyclocondensation reaction step, after the Knoeve-
nagel condensation step, make the approach between the two
molecules difﬁcult. This is the probable explanation for the poor
yields in the synthesis of 3-(naphth-1-oyl) derivatives (4af–ef).
It is also noteworthy that a great difference between the
melting points has been reported [3] and the same was found for
the compounds synthesized by us in the present study, i.e., 4aa
(28 8C), 4ae (35 8C), 4be (29 8C), 4ce (43 8C) and for 4de (25 8C).
Although the physical data of these ﬁve molecules were reported
[3], the melting point differences obliged us to perform a complete
structural re-investigation, to include 13C NMR and MS experi-
ments, as well as an X-ray diffraction measurement for 4aa, and a
CHN microanalysis to verify their purity.
Compounds 4 are constituted by a 3,4,7,8-tetrahydro-2H-
chromen-5(6H)-one ring which is the core of the structure and it
has four main substituents attached: a hydroxyl and a triﬂuor-
omethyl group at the C2-position and an acyl and an aryl
substituent at the C3- and C4-positions, respectively. The
structures of compounds 4 were deduced from 1H and 13C NMR
uni- and bi-dimensional experiments, in DMSO-d6 as solvent
(COSY, HSQC, HMBC andDEPT 135),MS, IR and by comparisonwith
NMR data of other 3,4,7,8-tetrahydro-2H-chromen-5(6H)-ones
previously synthesized [3], and the purity grade was proven by
CHN elemental analysis.
From the described reaction (Scheme 1), compounds 4 show
three stereocenters and eight stereoisomers would be expected,
among these, four pairs of enantiomers. If four pairs of enantiomers
were formed both 1H and13C NMR spectra should show four sets of
signals. However, the NMR spectra showed only one set of signals,
which indicates that only one pair of enantiomers was obtained.
Most of the compounds 4 (24 examples) showed an important
feature in the 1H NMR spectra, in DMSO-d6. The methyne protons
(H3, H4) are shown as a typical AX system as two doublets, in
which, one of them is on average at d 4.22 ppm (H3) and the other
at d 3.87 ppm (H4), with a vicinal coupling constant 3JHH = 12 Hz,
indicating a typical trans-axial conﬁguration of these two
hydrogen atoms. However, the 1H NMR spectra showed signals
for H3 and H4 for four 3-(4-ﬂuorobenzoyl) substituted chrome-
nones (4ac, 4bc, 4dc and 4ec; Y = H, Me, NO2 and CHO) and for two
3-benzoyl substituted (4db and 4eb; Y = NO2 and CHO) as one
unique and broad peak in the range of d 4.3 ppm, corresponding to
a typical AB system.The 13C{1H}NMR spectra exhibited only one set of peaks for
chromenones 4, despite the fact that three stereogenic carbons are
present in eachmolecule. Due to the presence of the CF3 group, the
C-2 carbon presented a characteristic quartet at d 94.6 ppm with
2JCF = 33 Hz. Also, the CF3 group showed a typical quartet at d
121.7 ppm with 1JCF = 287 Hz and the endo-cyclic carbonyl carbon
C-5 showed NMR signals in the range of d 194.9 ppm. Due to the
substituent effects on the structures of 4, the exo-cyclic carbonyl
carbon attached to C-3 revealed signals from d 182.2 to 204.1 ppm
(Dd = 21.9 ppm), the C-3 from d 47.7 to 58.3 ppm (Dd = 10.6 ppm)
and C-4, which is attached to the p-substituted aryl moiety derived
from the aldehyde precursors, showed signals in the narrow range
of d 27.6–28.2 ppm (Dd = 0.6 ppm).
Complementarily, the X-ray diffraction measurement was
carried out for compound 4aa (Fig. 1) [16] proving that H3 and
H4 are situated trans to each other, as are the substituents attached
to these carbons. The X-ray data demonstrated that the proton
attached to oxygen O21 of hydroxyl group presents, according to
the literature [22], a possible intramolecular H-bond with the
oxygen O32 of the carbonyl group [D(O32  H21) = 2.224 A˚ and
(O32  O21) = 3.019 A˚].
Thus, the X-ray diffraction and the NMR data conﬁrmed that
only one pair of enantiomers was obtained. Since the cyclization
reaction is essentially driven by thermodynamic factors where
the position of the substituents will depend on the steric factors,
as well as the stability of the resulting products, Fig. 1 represents
one enantiomer of the most stable possible structure for
compounds 4.
Finally, we would like to report that we are conducting studies
on the reactivity of the described 3,4,7,8-tetrahydro-2H-chromen-
5(6H)-ones. Preliminary results have demonstrated that chrome-
none 4aa reacts with hydrazine hydrate to furnish 5-triﬂuor-
omethyl-3-methyl-4-(2-benzyl-3-hydroxycyclohex-2-enone-2-
yl)-1H-pyrazole as an oil, by a new ring transformation reaction.
Scheme 3. Examples of reactivity studies on chromenone 4aa.
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aromatizing the cyclohexanone fragment to give the respective 5-
methoxy-3,4-dihydro-2H-chromene, but hindering dehydration.
Thus the hemiacetal function at carbon-2 of the pyran ring remains
(Scheme 3).
3. Conclusion
In summary, we have developed a new, simple and convenient
MCR protocol of wide scope for the synthesis of triﬂuoromethyl
substituted 3,4,7,8-tetrahydro-2H-chromen-5(6H)-ones starting
from commercially available 1,3-cyclohexanedione and aryl
aldehydes and, for the ﬁrst time, 4-methoxy-1,1,1-triﬂuoroalk-3-
en-2-ones, which proved to be a useful synthetic block to attach a
CF3 group at the heterocycles.
4. Experimental
4.1. Synthesis
Unless otherwise indicated all common reagents and solvents
were as obtained from commercial suppliers without further
puriﬁcation. All melting points were determined on a Reichert
Thermovar apparatus. 1H, 13C and 19F NMR spectra were acquired
on a Bruker DPX 400 (1H at 400.13 MHz and 19F at 376.3 MHz) and
Varian Mercury Plus 400 AS spectrometers (13C at 100.60 MHz),
5 mm sample tubes, 298 K, digital resolution 0.01 ppm, 260 pt/
ppm, in DMSO-d6 as solvent, using TMS as internal reference (0.05%
v/v, 1H and 13C) or ﬂuorobenzene as external reference (19F). Mass
spectra were registered in an Agilent 6460 Triple Quad LC/MS
connected to a 1200 series LC and equipped with a solvent degasser,
binary pump, column oven and auto-sampler. Samples were eluted
employing amixture of acetonitrile:water (40:60 v/v), as themobile
phase. The CHN elemental analyses were performed on a Perkin
Elmer 2400 CHN Elemental Analyzer (Sa˜o Paulo University-USP/
Brazil). The diffraction measurements were carried out by graphite-
monochromatized Mo Ka radiation with l = 0.71073 A˚ on a Bruker
SMART CCD diffractometer [17]. The structure of 4aa was solved
with direct methods using SHELXS-97 program [18], and reﬁned on
F2 by full-matrix least-squares by the SHELXL-97 package [19]. The
absorption correction was performed by Gaussian methods [20].
Anisotropic displacement parameters for non-hydrogen atomswere
applied. The hydrogen atoms were placed at calculated positions
with 0.96 A˚ (methyl CH3), 0.97 A˚ (methylene CH2), 0.98 A˚ (methyne
CH), 0.93 A˚ (aromatic CH) and 0.82 A˚ (OH) using a riding model. The
hydrogen isotropic thermal parameters were kept equal to
Uiso(H) = xUeq (carrier C atom), with x = 1.5 for methyl groups
and x = 1.2 otherwise. The valence angles C–C–H and H–C–H of
methyl groups were set to 109.58 and the H atoms were allowed to
rotate around the C–C bond. Molecular graph was prepared using
ORTEP3 for Windows [21].4.2. General procedure for the synthesis of 3-acyl-4-aryl-2-
(triﬂuoromethyl)-2-hydroxy-3,4,7,8-tetrahydro-2H-chromen-5(6H)-
ones (4)
4.2.1. General procedure
To a stirred mixture of aryl aldehydes (2.0 mmol), 1,3-
ciclohexanedione (0.224 g, 2.0 mmol) and 4-methoxy-1,1,1-tri-
ﬂuoroalk-3-en-2-ones (2.0 mmol) in EtOH (15 mL) was added
triethylamine (0.5 mmol, 50 mg) in a catalytic amount at room
temperature. Immediately, the solid products started to precipi-
tate. Then, the mixture was stirred under reﬂux for more 16 h.
After this time, the desired products were ﬁltered, washed with
cold EtOH, air-dried and a recrystallization from ethanol/
ethylacetate (2:1) and drying in a desiccator under reduced
pressure over P2O5, furnished 4 in high purity (elemental
analysis).
4.2.1.1. 3-Acetyl-2-hydroxy-4-phenyl-2-(triﬂuoromethyl)-3,4,7,8-
tetra-hydro-2H-chromen-5(6H)-one (4aa). White solid, yield 45%, mp
175–176 8C; (Lit. [3]: 203–204 8C). 1H NMR (DMSO-d6): d = 9.02 (s,
1H, OH), 7.09–7.25 (m, 5H, Ar), 4.00 (d, J = 12 Hz, 1H, H3), 2.99 (d,
J = 12 Hz, 1H, H4), 2.62–2.50 (m, 2H, H6), 2.20–2.17 (m, 2H, H8),
1.97 (s, 3H, Ac.), 1.94–1.88 (m, 2H, H7).
13C NMR (DMSO-d6): d = 203.9 (C5O, Ac.), 194.9 (C5), 166.3
(C8a), 141.3, 128.2, 127.2, 126.3 (Ar), 121.9 (q, 1JCF = 287 Hz, CF3),
114.6 (C4a), 94.1 (q, 2JCF = 33 Hz, C2), 58.1 (C3), 37.4 (C6), 36.4 (s,
3H, Ac.), 29.5 (C8), 27.8 (C4), 19.4 (C7).
19F NMR (DMSO-d6): d = 81.04 (CF3). MS (ESI) m/z: [(M+H)+,
355.2]. IR (KBr) nmax: 3303, 1725, 1604, 1358, 1229, 1190, 1165,
1040, 950 cm1. Anal. Calcd. for C18H17F3O4 (354.11): C, 61.02; H,
4.84%. Found: C, 61.01; H, 4.78%.
4.2.1.2. 3-Benzoyl-2-hydroxy-4-phenyl-2-(triﬂuoromethyl)-3,4,7,8-
tetrahydro-2H-chromen-5(6H)-one (4ab). White solid, yield 54%, mp
187–189 8C. 1H NMR (DMSO-d6): d = 8.57 (s, 1H, OH), 7.46–7.44
(m, 3H, Ar), 7.32–7.28 (m, 2H, Ar), 7.14–7.05 (m, 4H, Ar), 6.96 (m,
1H, Ar), 4.24 (d, J = 12 Hz, 1H, H3), 4.19 (d, J = 12 Hz, 1H, H4), 2.63–
2.58 (m, 2H, H6), 2.26–2.19 (m, 2H, H8), 1.98–1.95 (m, 2H, H7).
13C NMR (DMSO-d6): d = 195.9 (C5O, Bz), 194.4 (C5), 165.8
(C8a), 141.0, 137.7, 132.7, 128.0, 127.6, 127.1, 127.0, 125.7 (Ar),
122.0 (q, 1JCF = 287 Hz, CF3), 114.8 (C4a), 94.5 (q,
2JCF = 33 Hz, C2),
49.0 (C3), 38.3 (C6), 36.3 (C8), 27.6 (C4), 19.3 (C7).19F NMR (DMSO-
d6): d = 80.33 (CF3). MS (ESI) m/z: [(M+H)+, 417.1], [(M+Na)+,
439.0], [(M+K)+, 455]. IR (KBr) nmax: 3344, 1683, 1608, 1359, 1243,
1186, 1160, 1001 cm1. Calcd. for C23H19F3O4 (416.12): C, 66.34; H,
4.60%. Found: C, 66.07; H, 4.93%.
4.2.1.3. 3-(4-Fluorobenzoyl)-2-hydroxy-4-phenyl-2-(triﬂuoro-
methyl)-3,4,7,8-tetrahydro-2H-chromen-5 (6H)-one (4ac). White
solid, yield 60%, mp 173–175 8C. 1H NMR (DMSO-d6): d = 8.62 (s,
1H, OH), 7.99–7.95 (m, 1H, Ar), 7.59–7.55 (m, 2H, Ar), 7.13–7.11
(m, 2H, Ar), 7.09–7.01 (m, 4H, Ar), 4.27 (s, 2H, H3, H4), 2.63–2.56
(m, 2H, H6), 2.23–2.20 (m, 2H, H8), 2.04–1.95 (m, 2H, H7).
H.G. Bonacorso et al. / Journal of Fluorine Chemistry 132 (2011) 160–165 16513C NMR (DMSO-d6): d = 194.6 (C5O, Bz), 194.4 (C5), 165.9
(C8a), 164.4 (d, 1JCF = 253 Hz, Ar), 140.9, 133.9 (Ar), 130.1 (d,
3JCF = 9 Hz, Ar), 127.6, 127.2, 125.8 (Ar), 121.6 (q,
1JCF = 287 Hz,
CF3), 115.1 (d,
2JCF = 22 Hz, Ar), 114.8 (C4a), 94.6 (q,
2JCF = 33 Hz,
C2), 49.0 (C3), 38.7 (C6), 36.3 (C8), 27.7 (C4), 19.3 (C7).
19F NMR (DMSO-d6): d = 80.37 (CF3), 105.0 (4-FPh). MS (ESI)
m/z: [(M+H)+, 435.1], [(M+Na)+, 457.2]. IR (KBr) nmax: 3453, 1688,
1603, 1358, 1241, 1188, 1160, 845 cm1. Anal. Calcd. for
C23H18F4O4 (434.11): C, 63.60; H, 4.18%. Found: C, 63.70; H, 4.46%.
4.2.1.4. 3-(Furan-2-oyl)-2-hydroxy-4-phenyl-2-(triﬂuoromethyl)-
3,4,7,8-tetrahydro-2H-chromen-5(6H)-one (4ad). Yellow solid, yield
47%, mp 190–191 8C. 1H NMR (DMSO-d6): d = 8.55 (s, 1H, OH),
7.76–7.75 (m, 1H, Fur), 7.12–7.03 (m, 5H, Ph), 7.00–6.96 (m, 1H,
Fur), 6.48–6.47 (m, 1H, Fur), 4.16 (d, J = 12 Hz, 1H, H3), 3.88 (d,
J = 12 Hz, 1H, H4), 2.62–2.55 (m, 2H, H6), 2.21–2.18 (m, 2H, H8),
1.98–1.92 (m, 2H, H7).
13C NMR (DMSO-d6): d = 195.0 (C5); 182.9 (C5O, Fur), 166.3
(C8a), 152.3 (Fur), 148.6 (Fur), 141.2, 127.8, 127.6, 126.0 (Ph), 121.8
(q, 1JCF = 287 Hz, CF3), 119.5 (Fur), 115.0 (C4a), 112.6 (Fur), 94.8 (q,
2JCF = 33 Hz, C2), 49.5 (C3), 38.2 (C6), 36.5 (C8), 27.9 (C4), 19.6 (C7).
19F NMR (DMSO-d6): d = 80.67 (CF3). MS (ESI) m/z: [(M+H)+,
407.1], [(M+Na)+, 429.1]. IR (KBr) nmax: 3447, 1673, 1608, 1426,
1358, 1189, 1163, 1040, 764, 732 cm1. Anal. Calcd. for C21H17F3O5
(406.10): C, 62.07; H, 4.22%. Found: C, 61.94; H, 4.51%.
4.2.1.5. 2-Hydroxy-4-phenyl-3-(thien-2-oyl)-2-(triﬂuoromethyl)-
3,4,7,8-tetrahydro-2H-chromen-5(6H)-one (4ae). White solid, yield
50%, mp 187–189 8C; (Lit. [3]: 222–223 8C). 1H NMR (DMSO-d6):
d = 8.55 (s, 1H, OH), 7.80 (d, J = 5 Hz, 1H, Th), 7.41 (s, 1H, Th), 7.07–
7.04 (m, 4H, Ar), 6.97–6.96 (m, 2H, Ph/Th), 4.19 (d, J = 12 Hz, 1H,
H3), 3.98 (d, J = 12 Hz, 1H, H4), 2.62–2.57 (m, 2H, H6), 2.20–2.18
(m, 2H, H8), 1.97–1.95 (m, 2H, H7).
13C NMR (DMSO-d6): d = 194.6 (C5), 188.1 (C5O, Th), 166.0
(C4a), 144.5 (Th), 140.9 (Ph), 135.7 (Th), 132.9 (Th), 128.2 (Ph),
127.6 (Th), 127.3, 125.8 (Ph), 121.7 (q, 1JCF = 287 Hz, CF3), 114.9
(C4a), 94.6 (q, 2JCF = 33 Hz, C2), 50.9 (C3), 38.6 (C6), 36.3 (C8), 27.8
(C4), 19.4 (C7).
19F NMR (DMSO-d6): d = 81.41 (CF3). MS (ESI) m/z: [(M+H)+,
423.0], [(M+Na)+, 445.0]. IR (KBr) nmax: 3420, 1659, 1609, 1361,
1259, 1189, 1163, 1020, 729, 709 cm1. Anal. Calcd. for
C21H17F3O4S (422.08): C, 59.71; H, 4.06%. Found: C, 59.81; H, 4.32%.
4.2.1.6. 2-Hydroxy-3-(naphth-1-oyl)-4-phenyl-2-(triﬂuoromethyl)-
3,4,7,8-tetrahydro-2H-chromen-5(6H)-one (4af). White solid, yield
12%, mp 199–200 8C. 1H NMR (DMSO-d6): d = 8.70 (s, 1H, OH), 8.37
(d, J = 8.0 Hz, 1H, Ar), 7.97 (d, J = 8 Hz, 1H, Ar) 7.90 (d, J = 8 Hz, 1H,
Ar), 7.60–7.51 (m, 2H, Ar), 7.24–7.11 (m, 5H, Ar), 7.07–7.05 (m, 1H,
Ar), 6.88 (d, J = 7 Hz, 1H, Ar), 4.37 (d, J = 12 Hz, 1H, H3), 4.17 (d,
J = 12 Hz, 1H, H4), 2.64–2. 53 (m, 2H, H6), 2.25–2.22 (m, 2H, H8),
2.00–1.97 (m, 2H, H7).
13C NMR (DMSO-d6): d = 197.0 (C5O, Naph.), 194.7 (C5), 166.0
(C8a), 141.6, 135.3, 133.0, 132.8, 129.2, 128.0, 127.9, 127.5, 127.3,
127.2, 126.2, 125.9, 125.1, 123.8 (Ar), 120.7 (q, 1JCF = 287 Hz, CF3),
114.8 (C4a), 94.6 (q, 2JCF = 33 Hz, C2), 52.7 (C3), 38.2 (C6), 36.3 (C8),
27.7 (C4), 19.4 (C7).
19F NMR (DMSO-d6): d = 77.0 (CF3). MS (ESI)m/z (%): [(M+H)+,
467.1], [(M+Na)+, 489.1]. IR (KBr) nmax: 3428, 1678, 1607, 1349,
1230, 1193, 1039, 1016, 736, 654 cm1. Anal. Calcd. for C27H21F3O4
(466.14): C, 69.52; H, 4.54%. Found: C, 69.09; H, 5.01%.
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